跳至主要内容
临床试验/JPRN-jRCT1032230028
JPRN-jRCT1032230028招募中Unknown

Direct hemoperfusion with PMMA to adsorb uremic toxins in hemodialysis patients - PMMA-DHP

Yamamoto Suguru0 个研究点目标入组 10 人开始时间: 2023年4月16日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • Patients who meet all the inclusion criteria below,
  • 1. Patients who can obtain written informed consent to participate in this study based on their free will.
  • 2. Patients who are more than 18 years old.
  • 3. Patients undergoing hemodialysis treatment for 4 hours/session and three times a week.
  • 4. Patients with dialysis-related amyloidosis have the criteria to use FT-75 and FT-145.
  • 5. Patients who do not have residual kidney function.
  • 6. Patients with systolic blood pressure at pre-dialysis over 100 mmHg.
  • 7. Patients whose blood hemoglobin at pre-dialysis is more than 10.5 g/dL.

排除标准

  • Patients who meet any exclusion criteria are below.
  • 1. Patients who participate in other clinical studies.
  • 2. Patients who are pregnant or want pregnancy.
  • 3. Patients that the investigators decide are inappropriate to join the study.

研究者

发起方
Yamamoto Suguru

相似试验